Clinical Practice

Use the tool below to view all available Global Neurology Academy Series

Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
- Brian P. McDonough, MD, FAAFP
- John Corboy, MD, MA
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
NeuroFrontiers
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
- Ashley Baker, MSN, PMHNP
- Desiree Matthews, PMHNP-BC
- Rakesh Jain, MD, MPH
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
NeuroFrontiers
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
- Ashley Baker, MSN, PMHNP
- Rakesh Jain, MD, MPH
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
- Jasmohan Bajaj, MD
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiers
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
- Charles Turck, PharmD, BCPS, BCCCP
- Nadia Merchant, MD
- Melody Shi, MD
- Despoina Galetaki, MD
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
NeuroFrontiers
Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
Public Health Disparities in Alzheimer's Disease and Brain Health
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD